SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix (NFLX) is trending after its latest earnings report, revealing strong ad-tier growth and expanding margins, yet the stock saw a notable decline following cautious forward guidance and the cessation of share buybacks. The community is sharply divided, with many seeing this as a prime long-term buying opportunity, while others anticipate further downside, citing the potential Warner Bros. Discovery acquisition's impact on debt and shareholder value. This pivotal moment highlights a tug-of-war between Netflix's core business strength and strategic M&A concerns.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Gold is surging to new all-time highs, propelled by escalating geopolitical tensions stemming from recent tariff threats against European nations and discussions around Greenland. The community views this as a significant risk-off catalyst, driving substantial safe-haven inflows amid broader concerns over global stability and the dollar's future. While many anticipate further gains, calls for caution and potential profit-taking are also emerging as the metal's ascent becomes parabolic.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to multiple analyst upgrades and recent news of a significant U.S. SHIELD defense contract for chip supply, which the community views as a major catalyst. Investors are actively discussing the upcoming earnings, robust demand for server CPUs driven by AI, and the stock's notable resilience amidst broader market volatility, with many anticipating a move past key resistance levels.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid significant market uncertainty, driven by recent geopolitical rhetoric concerning Greenland and potential tariffs. While some investors anticipate a quick V-shaped rebound, others are bracing for further downside, with rising gold prices reflecting broader market anxiety. The community is actively debating whether these developments are temporary "noise" or signal a more substantial correction, especially considering underlying bond market concerns.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending due to reports of a potential acquisition by Zydus Lifesciences, sparking community speculation about a bidding war for the undervalued biotech. This is amplified by recent strong preliminary financial results, accelerated IBSRELA revenue guidance to $1 billion by 2029, and a pivotal patent extension to 2041 for both its key therapies. These developments firmly position Ardelyx as a compelling long-duration asset and an attractive target in the current biotech market landscape.

America's Oil Reserve for the Digital Age

U.S Oil

USOR Crypto is trending amidst extreme volatility, with community members fiercely debating its legitimacy as a Solana meme coin following a rapid price surge. While some anticipate significant further gains leading up to a key February 1st date, others are cautioning against a potential "rug pull" scenario, with many also discussing its inconsistent availability on various exchanges.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending amidst significant market uncertainty driven by former President Trump's recent geopolitical rhetoric concerning Greenland and tariffs, coupled with anticipation of his upcoming Davos speech. This has spurred intense community debate, with some advocating to "buy the dip" while others voice concerns over a potential market downturn, especially as gold prices reach new all-time highs.

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Anteris Technologies Global Corp.

Anteris Technologies Global

Anteris Technologies (AVR) is currently trending following news of a significant public offering and a strategic private placement to Medtronic, exciting investors about potential validation and future prospects. The community is actively discussing the implications of this institutional investment and the concurrent start of its pivotal PARADIGM trial for the DurAVR heart valve, balancing optimism with concerns over share dilution.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group ($DJT) is trending as conversations focus on President Trump's highly anticipated address at the World Economic Forum in Davos, following an unexpected return of Air Force One due to a mechanical issue. His rhetoric on imposing tariffs against European allies, especially regarding Greenland, is dominating community discussions, sparking concerns about global economic stability and the strength of international alliances. While many supporters view his assertive stance as decisive, critics are expressing apprehension over potential diplomatic fallout and its broader market impact.

Kinross Gold Corp. engages in the production, acquisition, exploration, and development of gold properties. The firm operates through the following business segments: Tasiast, Paracatu, La Coipa, Fort Knox, Round Mountain, Bald Mountain, and Corporate & Other. The Fort Knox segment includes Fort Knox and Manh Choh mine. Its mining operations are in the United States, Brazil, Chile, Mauritania, and Canada. The company was founded by Robert MacKay Buchan on May 31, 1993 and is headquartered in Toronto, Canada.

Kinross Gold Corp.

Kinross Gold is trending as gold prices surge to record highs, fueling strong investor optimism around the precious metals sector. The community is actively discussing Kinross's robust operational performance, significant free cash flow, and strategic growth projects, which are positioning the company as a top performer.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nordea Investment Management AB Grows Position in Arvinas, Inc. $ARVN

Nordea Investment Management AB raised its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 28.7% during the third quarter, according to its most recent filing with the Securities and...

Arvinas, Inc. $ARVN Stock Position Boosted by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 307.7% during the third quarter, according to its most recent disclosure with the...

Arvinas, Inc. (NASDAQ:ARVN) Short Interest Down 27.9% in December

Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totaling 4,859,281...

Arvinas (NASDAQ:ARVN) Shares Gap Up - Time to Buy?

Arvinas (NASDAQ:ARVN) Shares Gap Up - Time to Buy...

Arvinas (NASDAQ:ARVN) Shares Down 2.6% - Should You Sell?

Arvinas (NASDAQ:ARVN) Trading Down 2.6% - Should You Sell...

Arvinas, Inc. (NASDAQ:ARVN) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) have been assigned a consensus rating of "Hold" from the twenty-three research firms that are presently covering the company, MarketBeat.com...

Caxton Associates LLP Takes $2.19 Million Position in Arvinas, Inc. $ARVN

Caxton Associates LLP bought a new stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 298,062 shares of the...

Armistice Capital LLC Invests $4.12 Million in Arvinas, Inc. $ARVN

Armistice Capital LLC acquired a new stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 560,000...

Arvinas, Inc. (NASDAQ:ARVN) Receives Average Recommendation of "Hold" from Analysts

Shares of Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) have been assigned an average rating of "Hold" from the twenty-three research firms that are currently covering the stock, Marketbeat reports...

Velan Capital Investment Management LP Takes Position in Arvinas, Inc. $ARVN

Velan Capital Investment Management LP bought a new position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the second quarter, according to its most recent 13F filing with the...

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Arvinas Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

ARVN
Arvinas Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ARVN News

ARVNArvinas Inc